Login Register Cart 0
Generic placeholder image

Current Respiratory Medicine Reviews

Editor-in-Chief

ISSN (Print): 1573-398X
ISSN (Online): 1875-6387

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Role of Noninvasive Positive Pressure Ventilation in Chronic Obstructive Pulmonary Disease

Author(s): Hanin Abdulbaset Abo Taleb*

Volume 15, Issue 4, 2019

Page: [260 - 265] Pages: 6

DOI: 10.2174/1573398X15666191018152439

Abstract

Since 1980, continuous positive airway pressure technology (CPAP) has been one of the most effective treatment methods for obstructive airway disease. About 10 years later, Bi-level Positive Airway Pressure (BiPAP) had been developed with a more beneficial concept. CPAP and BiPAP are the most common forms of noninvasive positive pressure ventilation (NIPPV). CPAP administrates a single, constant, low-pressure air to maintain airway expansion throughout the respiratory cycle, while BiPAP gives high and low levels of pressure; one during inspiration (IPAP) and another during expiration (EPAP) to regulate breathing pattern and to keep airways expanded. Recently, much evidence suggests NIPPV in form of CPAP or BiPAP as a treatment option for Chronic Obstructive Pulmonary Disease (COPD) to improve blood gas abnormality and to reduce mortality rate, as well as to decrease the requirement of invasive mechanical ventilation and hospitalization. A guide for health care professionals released in 2019 has confirmed the use of NIPPV in COPD patients during exacerbation and if combined with obstructive sleep apnea. However, the treatment of stable COPD patients with hypercapnia or post-hospitalization COPD patients due to exacerbation with long term home NIPPV has not yet been adopted. Thus, COPD patient status and the timing of NIPPV delivery should be clearly evaluated. This mini review aims to show the role of NIPPV technology as an additional treatment option for patients suffering from COPD.

Keywords: BiPAP, chronic bronchitis, COPD, CPAP, emphysema, NIPPV, OSA, respiratory distress.

« Previous Next »
Graphical Abstract

[1]
Antonescu-Turcu A, Parthasarathy S. CPAP and bi-level PAP therapy: new and established roles. Respir Care 2010; 55(9): 1216-29.
[PMID: 20800002]
[2]
Donovan LM, Boeder S, Malhotra A, Patel SR. New developments in the use of positive airway pressure for obstructive sleep apnea. J Thorac Dis 2015; 7(8): 1323-42.
[PMID: 26380760]
[3]
Sullivan CE, Issa FG, Berthon-Jones M, Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981; 1(8225): 862-5.
[http://dx.doi.org/10.1016/S0140-6736(81)92140-1] [PMID: 6112294]
[4]
Sanders MH, Kern N. Obstructive sleep apnea treated by independently adjusted inspiratory and expiratory positive airway pressures via nasal mask. Physiologic and clinical implications. Chest 1990; 98(2): 317-24.
[http://dx.doi.org/10.1378/chest.98.2.317] [PMID: 2198134]
[5]
Wahab NA, Yasser NA. Optimal level of continuous positive airway pressure: Auto-CPAP titration versus predictive formulas. Egyptian Journal of Chest Diseases and Tuberculosis 2017; 66(2): 353-61.
[6]
Spicuzza L, Caruso D, Di Maria G. Obstructive sleep apnoea syndrome and its management. Ther Adv Chronic Dis 2015; 6(5): 273-85.
[http://dx.doi.org/10.1177/2040622315590318] [PMID: 26336596]
[7]
Seyfi S, Amri P, Mouodi S. New modalities for non-invasive positive pressure ventilation: A review article. Caspian J Intern Med 2019; 10(1): 1-6.
[PMID: 30858934]
[8]
Hess DR. Noninvasive ventilation in neuromuscular disease: equipment and application. Respir Care 2006; 51(8): 896-911.
[PMID: 16867200]
[9]
Moy HP, Bruton B. Evidence-Based EMS: Out-of-Hospital BiPAP vs CPAP. Is one any better than the other? EMS World 2016; 45(1): 36-38, 40.
[PMID: 26852544]
[10]
Nickol AH, Hart N, Hopkinson NS, et al. Mechanisms of improvement of respiratory failure in patients with COPD treated with NIV. Int J Chron Obstruct Pulmon Dis 2008; 3(3): 453-62.
[http://dx.doi.org/10.2147/COPD.S2705] [PMID: 18990974]
[11]
Poehacker S, Garg M, Drossel C. “Chronic obstructive pulmonary disease” Principle-based stepped care and brief psychotherapy for integrated care settings. Springer 2018; pp. 113-28.
[http://dx.doi.org/10.1007/978-3-319-70539-2_11]
[12]
Wali SO, Idrees MM, Alamoudi OS, et al. Prevalence of chronic obstructive pulmonary disease in Saudi Arabia. Saudi Med J 2014; 35(7): 684-90.
[PMID: 25028224]
[13]
Heron M. Deaths: Leading Causes for 2016. Natl Vital Stat Rep 2018; 67(6): 1-77.
[PMID: 30248017]
[14]
McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA. TORCH Clinical Endpoint Committee. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 2007; 62(5): 411-5.
[http://dx.doi.org/10.1136/thx.2006.072348] [PMID: 17311843]
[15]
Nazir SA, Erbland ML. Chronic obstructive pulmonary disease: an update on diagnosis and management issues in older adults. Drugs Aging 2009; 26(10): 813-31.
[http://dx.doi.org/10.2165/11316760-000000000-00000] [PMID: 19761275]
[16]
Kim V, Criner GJ. Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187(3): 228-37.
[http://dx.doi.org/10.1164/rccm.201210-1843CI] [PMID: 23204254]
[17]
Voelkel NF, Gomez-Arroyo J, Mizuno S. COPD/emphysema: The vascular story. Pulm Circ 2011; 1(3): 320-6.
[http://dx.doi.org/10.4103/2045-8932.87295] [PMID: 22140621]
[18]
Sharafkhaneh A, Hanania NA, Kim V. Pathogenesis of emphysema: from the bench to the bedside. Proc Am Thorac Soc 2008; 5(4): 475-7.
[http://dx.doi.org/10.1513/pats.200708-126ET] [PMID: 18453358]
[19]
Chillappagari S, Preuss J, Licht S, et al. Altered protease and antiprotease balance during a COPD exacerbation contributes to mucus obstruction. Respir Res 2015; 16(1): 85.
[http://dx.doi.org/10.1186/s12931-015-0247-x] [PMID: 26169056]
[20]
Abboud RT, Vimalanathan S. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema. Int J Tuberc Lung Dis 2008; 12(4): 361-7.
[PMID: 18371259]
[21]
Sherwood L. Human physiology from cells to systems. 9th ed. Cengage learning 2016,. 2013..
[22]
Verra F, Escudier E, Lebargy F, Bernaudin JF, De Crémoux H, Bignon J. Ciliary abnormalities in bronchial epithelium of smokers, ex-smokers, and nonsmokers. Am J Respir Crit Care Med 1995; 151(3 Pt 1): 630-4.
[http://dx.doi.org/10.1164/ajrccm/151.3_Pt_1.630] [PMID: 7881648]
[23]
Khan JH, Lababidi HM, Al-Moamary MS, et al. The saudi guidelines for the diagnosis and management of copd. Ann Thorac Med 2014; 9(2): 55-76.
[http://dx.doi.org/10.4103/1817-1737.128843] [PMID: 24791168]
[24]
Skjørten I, Hilde JM, Melsom MN, Hansteen V, Steine K, Humerfelt S. Pulmonary artery pressure and PaO2 in chronic obstructive pulmonary disease. Respir Med 2013; 107(8): 1271-9.
[http://dx.doi.org/10.1016/j.rmed.2013.03.021] [PMID: 23768734]
[25]
Downs JB. Physiological Effects of Increased Airway Pressure. In: Vincent JL, Ed. Proceedings of the 5th International Symposium on Intensive Care and Emergency Medicine. 1985 March 26-29; Berlin, Heidelberg. Brussels, Belgium: Springer 1985; pp. 20-3.
[26]
Kanathur N, Hirshkowitz M, Lee-Chiong TL. Positive Airway Pressure Therapy for Obstructive Sleep Apnea Therapy in Sleep Medicine 2012. WB Elsevier Inc. 2012; pp. 206-17.
[27]
Kushida CA, Chediak A, Berry RB, et al. Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med 2008; 4(2): 157-71.
[PMID: 18468315]
[28]
Pinto VL, Sharma S. Continuous Positive Airway Pressure (CPAP).[Updated 2019 May 11]. In: StatPearls. Treasure Island, (FL): StatPearls Publishing 2019 Jan-.Available from. https://www.ncbi.nlm.nih.gov/books/NBK482178/
[29]
Kato T, Suda S, Kasai T. Positive airway pressure therapy for heart failure. World J Cardiol 2014; 6(11): 1175-91.
[http://dx.doi.org/10.4330/wjc.v6.i11.1175] [PMID: 25429330]
[30]
Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: The gold science committee report 2019. Eur Respir J 2019; 53(5)1900164
[http://dx.doi.org/10.1183/13993003.00164-2019] [PMID: 30846476]
[31]
Murphy PB, Hart N. Home non-invasive ventilation for copd: How, who and when? Arch Bronconeumol 2018; 54(3): 149-54.
[PMID: 29371025]
[32]
Dial S, Menzies D. Is there a role for mask continuous positive airway pressure in acute respiratory failure due to COPD? Lessons from a retrospective audit of 3 different cohorts. Int J Chron Obstruct Pulmon Dis 2006; 1(1): 65-72.
[http://dx.doi.org/10.2147/copd.2006.1.1.65] [PMID: 18046904]
[33]
Ankjærgaard KL, Tønnesen P, Laursen LC, Hansen EF, Andreassen HF, Wilcke JT. Home Non Invasive Ventilation (NIV) treatment for COPD patients with a history of NIV-treated exacerbation; a randomized, controlled, multi-center study. BMC Pulm Med 2016; 16(1): 32.
[http://dx.doi.org/10.1186/s12890-016-0184-6] [PMID: 26867542]
[34]
Köhnlein T, Windisch W, Köhler D, et al. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med 2014; 2(9): 698-705.
[http://dx.doi.org/10.1016/S2213-2600(14)70153-5] [PMID: 25066329]
[35]
Reis MS, Reis H, Sobral DT, Catai AM, Silva AB. Effects of cpap on the physical exercise tolerance of moderate to severe chronic obstructive pulmonary disease. Jour Resp Cardiov Phy Ther 2016; 5(1): 13-21.
[36]
Zhou L, Li X, Guan L, et al. Home noninvasive positive pressure ventilation with built-in software in stable hypercapnic COPD: a short-term prospective, multicenter, randomized, controlled trial. Int J Chron Obstruct Pulmon Dis 2017; 12: 1279-86.
[http://dx.doi.org/10.2147/COPD.S127540] [PMID: 28490871]
[37]
Britton M. The burden of COPD in the U.K.: results from the Confronting COPD survey. Respir Med 2003; 97(Suppl. C): S71-9.
[http://dx.doi.org/10.1016/S0954-6111(03)80027-6] [PMID: 12647945]
[38]
Scala R, Heunks L. Highlights in acute respiratory failure. Eur Respir Rev 2018; 27(147)180008
[http://dx.doi.org/10.1183/16000617.0008-2018] [PMID: 29592866]
[39]
Galli JA, Krahnke JS, James Mamary A, Shenoy K, Zhao H, Criner GJ. Home non-invasive ventilation use following acute hypercapnic respiratory failure in COPD. Respir Med 2014; 108(5): 722-8.
[http://dx.doi.org/10.1016/j.rmed.2014.03.006] [PMID: 24702885]
[40]
Murphy PB, Rehal S, Arbane G, et al. Effect of home noninvasive ventilation with oxygen therapy vs. oxygen therapy alone on hospital readmission or death after an acute copd exacerbation: A randomized clinical trial. JAMA 2017; 317(21): 2177-86.
[http://dx.doi.org/10.1001/jama.2017.4451] [PMID: 28528348]
[41]
Funk G-C, Breyer M-K, Burghuber OC, et al. Long-term non-invasive ventilation in COPD after acute-on-chronic respiratory failure. Respir Med 2011; 105(3): 427-34.
[http://dx.doi.org/10.1016/j.rmed.2010.09.005] [PMID: 21111590]
[42]
Dretzke J, Moore D, Dave C, et al. The effect of domiciliary noninvasive ventilation on clinical outcomes in stable and recently hospitalized patients with COPD: A systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis 2016; 11: 2269-86.
[http://dx.doi.org/10.2147/COPD.S104238] [PMID: 27698560]

Rights & Permissions Print Cite
Article Metrics
4
1
© 2024 Bentham Science Publishers | Privacy Policy